Akari Therapeutics PLC · NASDAQ:AKTX
Akari Therapeutics PLC shareholders
As of Sep 30, 2026, 12 institutions reported holding Akari Therapeutics PLC, <0.01% of its shares. Largest: Vestmark Advisory Solutions, Inc., Jane Street and Citadel. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Akari Therapeutics PLC | Change | Filed |
|---|---|---|---|---|
| Vestmark Advisory Solutions, Inc. | 37,688 | <0.01% | new | Nov 16, 2026 |
| Jane Street | 23,242 | <0.01% | new | Nov 12, 2026 |
| Citadel | 21,637 | <0.01% | new | Nov 16, 2026 |
| Cresset Asset Management, LLC | 20,561 | <0.01% | new | Nov 16, 2026 |
| Occidental Asset Management, LLC | 18,125 | <0.01% | new | Nov 5, 2026 |
| MMCAP International Inc. SPC | 11,427 | <0.01% | new | Nov 12, 2026 |
| Tower Research Capital LLC (TRC) | 385 | <0.01% | new | Nov 16, 2026 |
| IFP Advisors, Inc | 181 | <0.01% | new | Oct 16, 2026 |
| Nuveen | 86 | <0.01% | new | Nov 10, 2026 |
| SBI Securities Co., Ltd. | 15 | <0.01% | new | Oct 21, 2026 |